Benjamin David is a Deputy Editor for Funds Europe and EIN Presswire. His articles focus on European markets, investment strategies, and global financial trends. Benjamin's work has also been featured in Infosecurity Magazine, where he covers topics related to cybersecurity and data protection.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
International
Benjamin David's coverage is focused on business and investment analysis, with a particular emphasis on ETFs, market trends, investing, and energy. He shows interest in press releases and data-backed content.
Benjamin would likely be receptive to pitches that provide unique insights into market trends or investment opportunities within the ETF space. Additionally, he might appreciate expert commentary from industry professionals who can offer valuable perspectives on global markets' movements and emerging investment products.
Given his focus on European markets as well as global investments such as the Lightspeed Faction blockchain fund and Octopus Energy's expansion into Germany, experts with an international perspective could also find success in pitching relevant stories or commentary to Benjamin.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Benjamin David
The firm has acquired a 5% share in the Butendiek offshore wind farm, located 32 km west of Sylt island in the North Sea.
In October 2023, global Exchange-Traded Products (ETPs) witnessed steady inflows, adding $66 billion, consistent with previous months
The survey, involving over 4,000 UK DC members, indicates that financial strain has not dampened their enthusiasm for ESG investments. Despite price hikes, 65% are more inclined to invest in renewable energy and sustainable food production to bolster the UK's long-term economic resilience.
Cellebration Wellness is excited to announce that it will be offering up to a 50% off discount to customers seeking stem cell treatment.
A rabbi is writing about the Olympic Trials? Well, yes. As a longtime runner and ardent fan of the sport, I am super excited about the rapidly approaching marathon trials in Orlando. In this article, I will analyze and give my odds for a total of 70 top men and women who will be toeing line on February 3. I have divided the main players into a series of groupings based on how likely I feel they are to make the team.
The U.S. Marathon Olympic trials happen every four years. It is a crazed, high-intensity event. It was my 3nd Trials attending in person. The top three become Olympians; everyone else goes home deflated.(See my trials preview for further details on Olympic qualifying).
By: Benjamin David
Aging department offers hands-on simulation involving Alzheimer's and other dementia diagnoses
By: Oguzhan, Wang, Huijue, Zhang, Yue, Lyu, Singer, Lu, Ping, Feng, Zhao
POU2AF2 is a co-activator of POU2F3 in normal and neoplastic tuft cells, such as small cell lung cancer. Here, the authors report that POU2AF2 dictates opposing transcriptional regulation at distal enhance elements.
By: Benjamin David
Costa Rica-based stem cell facility provides treatment for former professional athlete, Ron Brown
The Boston Marathon is a harbinger of good and has been for decades. Patriots Day signals that spring is here in earnest, the racing season has arrived and the dread of dreary winter has passed. Perpetually set against the backdrop of domestic or international strife, the Boston Marathon comes along and reminds us that we indeed know how to unify and achieve a modicum of peace and humanity together. Let’s get to it.
(833) 317-6278 
